A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived ...

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

No parent is prepared to learn their child has cancer, but here is Northwest Arkansas, one girl’s battle becomes an invisible ...

Before each home game, Buffalo Bills Quarterback Josh Allen wears a New Era cap customized by a patient at Oishei Children's Hospital, and this week, 12-year-old Charlie Roessler is the designer.

The alarming findings of a recent study reveal a hidden health crisis linked to medical imaging that could endanger children across America. A groundbreaking investigation published in the New England ...

In a clinical trial, six sessions of low-dose radiation significantly eased knee osteoarthritis pain and improved function ...

The PCS5 trial is a Canadian multicenter, open-label, phase III randomized trial that included men with histologically proven, clinically localized prostate cancer with ≥1 high-risk feature (s) ...

At a median follow-up of 19.6 months, the median PSA was 0.028 ng/mL. 18/100 patients developed biochemical recurrence, with a median time to recurrence of 10 months. The biochemical recurrence-free ...